News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Key Points The transaction involved 2,999 shares valued at $285,000 based on the August 5 transaction price. The disposal reduced Chesley's direct holdings by 6%. The transaction was entirely direct; Chesley retains 49,508 shares in direct ownership. The sale was non-discretionary, executed to cover …
Sharemaestro market context Trend signal active 52 weeks +7.0% · Next-week setup negative 1.3%Key Points The disposal involved 2,262 shares with an estimated value of $215,000 based on a weighted average price of $95.04 per share. The transaction reduced the insider's direct equity holdings by 4%. The shares were withheld by the company solely to cover tax …
Sharemaestro market context Trend signal active 52 weeks +7.0% · Next-week setup negative 1.3%Key Points This total disposition of 3,949 shares at $95.04 per share on August 5 was valued at about $375,313. The move represents a 3% reduction in direct equity holdings. The disposal was non-discretionary, executed to satisfy tax withholding obligations associated with a vesting …
Sharemaestro market context Trend signal active 52 weeks +7.0% · Next-week setup negative 1.3%Key Points A Qorvo executive disposed of 3,944 shares with a transaction value of roughly $374,838 on August 5. The non-discretionary disposition reduced the insider's direct equity position by 5%. Equity ownership is held entirely through direct holdings, with no indirect entities reported in …
Sharemaestro market context Trend signal active 52 weeks +7.0% · Next-week setup negative 1.3%Key Points The disposition involved 4,628 shares at $95.04 per share, representing a transaction value of roughly $440,000 on August 5. The automated move reduced the executive's direct equity holdings by 8%. The transaction was a non-discretionary tax withholding event tied to the vesting …
Sharemaestro market context Trend signal active 52 weeks +7.0% · Next-week setup negative 1.3%Key Points The executive disposed of 16,379 shares valued at about $1.6 million on August 5. The disposition represented 4% of the insider's direct equity holdings. All reported activity involved direct ownership, with no indirect holdings or entities listed in this transaction.10 stocks we …
Sharemaestro market context Trend signal active 52 weeks +7.0% · Next-week setup negative 1.3%Quantinno Capital Management LP significantly increased its stake in CorVel Corp. (NASDAQ:CRVL) by 328.4% in the first quarter, now holding 81,544 shares valued at $4.46 million. Institutional investors and hedge funds collectively own 51.36% of the company, while analyst sentiment is mixed but improving, …
Qorvo's SVP Global Operations, Paul J. Fego, reported a "code F" insider transaction on August 5, 2026, involving the delivery or withholding of 3,944 common shares. These shares, valued at $95.04 each, were used to cover exercise price or tax liability. Following this transaction, …
Corvus Pharmaceuticals (NASDAQ:CRVS) reported a quarterly loss of $0.19 per share, missing analyst expectations by $0.03. Despite the earnings miss, the company extended its cash runway into Q2 2028 after a $189.4 million follow-on offering and reported encouraging Phase I results for soquelitinib in …
Frank P. Stewart, SVP, Advanced Cellular at Qorvo, Inc. (NASDAQ: QRVO), reported a disposition of 2,262 shares of common stock on August 5, 2026. These shares were used to cover exercise price or tax liability at a price of $95.04 per share. Following this …
Sharemaestro market context Trend signal active 52 weeks +7.0% · Next-week setup negative 1.3%Steven E. Creviston, SVP of Connectivity & Sensors at Qorvo, Inc. (QRVO), withheld 3,949 common shares on August 5, 2026. This transaction, valued at $95.04 per share, was conducted to cover an exercise price or tax liability. Following this, Creviston directly holds 124,261 shares …
Qorvo (QRVO) reported improved profitability in Q1 fiscal 2027 with higher margins despite a revenue decline, suggesting a focus on higher-value business. The proposed $22 billion merger with Skyworks (SWKS) aims to create a larger, more diversified semiconductor supplier to address revenue growth challenges, …
Corvus Pharmaceuticals reported a Q2 2026 net loss of $18 million, more than double the previous year, primarily due to increased R&D spending on its lead drug candidate, soquelitinib. Despite the wider loss, the company has a strong cash position of $215.2 million, projected …
Antipodes Partners published its "Antipodes Global Strategy" second-quarter 2026 investor letter, highlighting the key performance stocks, portfolio changes, and the market outlook. A copy of the letter can be downloaded here. The second quarter of 2026 delivered one of the strongest equity market recoveries …
Sharemaestro market context Trend signal active 52 weeks +7.0% · Next-week setup negative 1.3%Corvus Pharmaceuticals reported its second-quarter 2026 financial results, highlighting that its cash, cash equivalents, and marketable securities reached $215.2 million, providing a runway into Q2 2028. The company is actively enrolling patients in Phase 3 trials for soquelitinib in relapsed/refractory peripheral T-cell lymphoma (PTCL) …
Corvus Pharmaceuticals reported a wider net loss of $(17.96)M and diluted EPS of $(0.19) for Q2 2026, compared to the year-ago quarter, as the company continues to invest heavily in clinical development. Despite the increased losses and no product revenue, Corvus Pharmaceuticals is progressing …
Corvus Pharmaceuticals reported a Q2 2026 net loss of $18.0 million, an increase from $8.0 million a year prior, primarily due to higher clinical trial and personnel costs for soquelitinib. The company maintains a strong cash position of $215.2 million, expected to fund operations …
Corvus Pharmaceuticals is set to release its second-quarter earnings, with investors focused on clinical trial progress for its lead drug candidate, soquelitinib, and its cash burn rate. The pre-revenue biotech is expected to post a loss of 15 cents per share, with current cash …
This article discusses how Qorvo's new 3D RF-SOI architecture, as seen in the QM18566 RF Antenna Tuner from the Apple iPhone 17 Pro, is revolutionizing smartphone RF front-end design. By using hybrid bonding with UMC's 55 nm 3DIC RF-SOI platform, Qorvo has created a …
Corvus Pharmaceuticals reported a wider Q2 loss due to increased R&D spending on soquelitinib trials, but its substantial cash position is expected to fund operations into Q2 2028. The company provided updates on its clinical programs, including the Phase III PTCL trial with an …
CorVel Corporation (CRVL) reported strong fiscal Q1 2027 results with revenue up 11% year-over-year to $260 million and EPS increasing 22% to $0.63. The growth was driven by equal contributions from Patient Management and Network Solutions, with CERIS being a key factor for the …
CorVel Corp (CRVL) reported a strong Q1 2027 with revenue up 11% to $260 million and EPS increasing 22% to $0.63, driven by new client implementations and a surge in claims volume. The company also announced new Executive Advisory Services and a data-driven medical …
CorVel Corp. reported a profit of $32.2 million in its fiscal first quarter, with net income reaching 63 cents per share. The Fort Worth, Texas-based healthcare management company achieved revenue of $259.9 million during this period. This financial report was generated using data from …
CorVel Corp. reported strong Q1 2026 results, with revenue up 11% to $260 million and EPS increasing 22% to $0.63, driven by increased claims volume and new customer sales. The company's shares jumped 7.59% following the announcement, reflecting positive investor reaction to its consistent …
Qorvo Inc. QRVO delivered a better-than-expected first quarter for fiscal 2027, offering investors fresh evidence that the company's profitability profile is improving even as smartphone demand remains under pressure. While revenues declined from a year ago, stronger margins, disciplined cost management and a more …
Sharemaestro market context Trend signal active 52 weeks +7.0% · Next-week setup negative 1.3%Investors evaluating Qorvo Inc. QRVO face a familiar dilemma. The company's profitability has improved markedly, supported by stronger execution and a healthier business mix. At the same time, uncertainty surrounding smartphone demand, customer concentration and the pending Skyworks transaction continues to limit near-term visibility. …
Sharemaestro market context Trend signal active 52 weeks +7.0% · Next-week setup negative 1.3%Shares of Qorvo Inc. QRVO have rallied 11.6% over the past month as investors responded to improving profitability and signs that the company's strategic repositioning is gaining traction. The latest advance naturally raises the question of whether fundamentals can continue supporting the stock or …
Sharemaestro market context Trend signal active 52 weeks +7.0% · Next-week setup negative 1.3%The article provides a brief financial snippet for CorVel Corp. (NASDAQ: CRVL), specifically focusing on its "Price to sales forward" metric. It appears to be an excerpt from a financial data platform, indicating the company's stock exchange listing and basic financial overview. The main …
CorVel Corporation reported strong financial results for the quarter ended June 30, 2026, with revenues increasing 11% to $259,925,000 and diluted earnings per share rising 21% to $0.63. The company maintained a solid cash position with no borrowings and repurchased $21.8 million of common …
CorVel (NASDAQ: CRVL) reported strong financial results for its first quarter of fiscal 2027, with revenues increasing 11% year-over-year to $259.9 million and diluted earnings per share rising 21% to $0.63. The company repurchased $21.8 million of common stock during the quarter and ended …
Search by ticker symbol or company name and select a result to open its chart.